Resalis Therapeutics Revenue and Competitors

Turin, IT

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Resalis Therapeutics's estimated annual revenue is currently $1.9M per year.(i)
  • Resalis Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Resalis Therapeutics has 12 Employees.(i)
  • Resalis Therapeutics grew their employee count by 9% last year.

Resalis Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.1M70%N/AN/A
#2
$1.9M129%N/AN/A
Add Company

What Is Resalis Therapeutics?

Resalis Therapeutics’ transformative metabolic disease approach targets a master regulator of key pathways underlying obesity and fatty liver disease. \n \nThe company is applying its unique understanding of the non-coding RNA drug modality and lipid metabolism to develop its lead program, RES-010, into a safe and convenient treatment providing disease-modifying therapeutic impact including durable weight loss and reduction of hepatic steatosis.\n\nBuilding on robust preclinical evidence, Resalis will rapidly bring RES-010 into clinical trials for a range of metabolic disorders.

keywords:N/A

N/A

Total Funding

12

Number of Employees

$1.9M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3M1623%N/A
#2
$6.7M2686%$11M
#3
$4.1M6930%$6M
#4
$8.2M70-9%$24M
#5
$7.8M78-1%N/A